Correction

Pembrolizumab plus Olaparib in Patients with Metastatic Castration-resistant Prostate Cancer: Long-term Results from the Phase 1b/2 KEYNOTE-365 Cohort A Study (vol 83, pg 15, 2023)

Journal

EUROPEAN UROLOGY
Volume 83, Issue 3, Pages E87-E87

Publisher

ELSEVIER
DOI: 10.1016/j.eururo.2022.11.025

Keywords

-

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Recommended

No Data Available
No Data Available